Number of suitable individuals: CDEC talked about the uncertainty in the volume of sufferers with reasonably critical to extreme hemophilia B in Canada eligible for etranacogene dezaparvovec. Medical professionals consulted by CADTH indicated that some clients who are categorized as getting delicate or moderate condition could possibly have a sever